TELEHEALTH MADE PERMANENT ACROSS STATE LINES A BIG WIN FOR PRESTODOCTOR AND AMERICA
MESQUITE, NV, Aug. 06, 2020 (GLOBE NEWSWIRE) — TELEHEALTH MADE PERMANENT ACROSS STATE LINES A BIG WIN FOR PRESTODOCTOR AND AMERICAMESQUITE, NV […]
Zealand Pharma hosts conference call on August 13 at 4 pm CET (10am ET) to present second quarter results for 2020
Press Release – No. 42 / 2020Zealand Pharma hosts conference call on August 13 at 4 pm CET (10am ET) […]
UP Fintech Holding Limited to Report Second Quarter 2020 Financial Results on August 18, 2020
BEIJING, Aug. 06, 2020 (GLOBE NEWSWIRE) — UP Fintech Holding Limited (“UP Fintech” or the “Company”) (NASDAQ: TIGR), a leading […]
Far Announces A New Advisory Board Member
VANCOUVER, British Columbia, Aug. 06, 2020 (GLOBE NEWSWIRE) — Far Resources Ltd (CSE:FAT) (FSE:F0R) (OTC:FRRSF).John Gammack, President and CEO, is […]
CGG: Annonce la Signature d’un Accord pour la Cession de ses Activités Multi-Physics
CGG Annonce la Signature d’un Accord pour la Cession de ses Activités Multi-PhysicsParis, France – 6 Août, 2020CGG annonce ce […]
CGG: Announces the Signature of an Agreement for the Sale of its Multi-Physics Business
CGG Announces the Signature of an Agreement for the Sale of its Multi-Physics BusinessParis, France – August 6, 2020CGG announced […]
TSX News -
Etrion Releases Second Quarter 2020 Results
GENEVA, Aug. 06, 2020 (GLOBE NEWSWIRE) — Etrion Corporation (“Etrion” or the “Company”) (TSX: ETX) (OMX: ETX), an independent renewable […]
Altera Infrastructure Reports Second Quarter 2020 Results
Revenues of $304 million and a net loss of $16 million, or $0.06 per common unit, in the second quarter of 2020Net […]
LexinFintech Holdings Ltd. to Report Second Quarter 2020 Unaudited Financial Results on August 18, 2020
SHENZHEN, China, Aug. 06, 2020 (GLOBE NEWSWIRE) — LexinFintech Holdings Ltd. (“Lexin” or the “Company”) (NASDAQ: LX), a leading online […]
ObsEva Announces Second Quarter 2020 Financial Results and Business Update
Primary endpoint successfully met in Phase 3 PRIMROSE 1 trial of linzagolix for the treatment of heavy menstrual bleeding due […]
